Patents by Inventor Hélène Nuyttens

Hélène Nuyttens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD4+ T survivin epitopes and uses thereof
    Patent number: 9687539
    Abstract: The present invention concerns CD4+ T survivin epitopes and their vaccines and diagnostic uses.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: June 27, 2017
    Assignee: Commissariat a l'Energie Atomique
    Inventors: XiaoFei Wang, Gaetan Munier, Sandra Moratille, Helene Nuyttens, Bernard Maillere
  • Method for diagnosing bacterial infections
    Patent number: 9528997
    Abstract: The invention concerns an in vitro method for determining if an individual is infected by a bacterium of the Propionibacterium genus comprising: (i) detecting antibodies directed against at least one protein of sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, in a biological sample of the individual, and (ii) deducing therefrom that the individual is infected by a bacterium of the Propionibacterium genus. The invention further concerns the kit for diagnosing of such an infection.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: December 27, 2016
    Assignee: Diaxonhit
    Inventors: Julie Rogé, Hélène Nuyttens, Karine Mignon Godefroy, Damien Thomas, Virginie Pinchot
  • Method for diagnosing and genera infections
    Patent number: 9103828
    Abstract: The invention concerns a method to determine if an individual is infected by a bacterium selected from the group consisting Streptococcus, Enterococcus and Peptostreptococcus genera comprising: (i) detection of antibodies directed against at least one protein of sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, in a biological sample of the individual, and (ii) deducing therefrom that the individual is infected by a bacterium selected from the group consisting of Streptococcus, Enterococcus and Peptostreptococcus genera. The invention further concerns the kit for diagnosing of such an infection.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: August 11, 2015
    Assignee: Diaxonhit
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • CD4+ T Survivin Epitopes and Uses Thereof
    Publication number: 20150050304
    Abstract: The present invention concerns CD4+ T survivin epitopes and their vaccines and diagnostic uses.
    Type: Application
    Filed: October 9, 2014
    Publication date: February 19, 2015
    Inventors: XiaoFei Wang, Gaetan Munier, Sandra Moratille, Helene Nuyttens, Bernard Maillere
  • Method for diagnosing gram-negative infections
    Patent number: 8785145
    Abstract: The invention concerns an in vitro method for determining if an individual is infected by a gram-negative bacterium preferably on prosthesis comprising: (i) detection of antibodies directed against a polypeptide of sequence SEQ ID NO: 2 and antibodies directed against a polypeptide of sequence SEQ ID NO: 4, in a biological sample of the individual, and (ii) deduction therefrom that the individual is infected by a gram-negative bacterium. The invention further concerns the kit for diagnosing of such an infection.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: July 22, 2014
    Assignee: Ingen Biosciences
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Method for Diagnosing Gram-Negative Infections
    Publication number: 20130040320
    Abstract: The invention concerns an in vitro method for determining if an individual is infected by a gram-negative bacterium preferably on prosthesis comprising: (i) detection of antibodies directed against a polypeptide of sequence SEQ ID NO: 2 and antibodies directed against a polypeptide of sequence SEQ ID NO: 4, in a biological sample of the individual, and (ii) deduction therefrom that the individual is infected by a gram-negative bacterium. The invention further concerns the kit for diagnosing of such an infection.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 14, 2013
    Applicant: INGEN BIOSCIENCES
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Method for Diagnosing Streptococcus, Enterococcus and Pepstostreptococcus Genera Infections
    Publication number: 20130040321
    Abstract: The invention concerns a method to determine if an individual is infected by a bacterium selected from the group consisting Streptococcus, Enterococcus and Peptostreptococcus genera comprising: (i) detection of antibodies directed against at least one protein of sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, in a biological sample of the individual, and (ii) deducing therefrom that the individual is infected by a bacterium selected from the group consisting of Streptococcus, Enterococcus and Peptostreptococcus genera. The invention further concerns the kit for diagnosing of such an infection.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 14, 2013
    Applicant: INGEN BIOSCIENCES
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Method for diagnosing staphylococcal infections
    Patent number: 8101190
    Abstract: The present invention relates to a method for determining if an individual is infected by a staphylococcus bacterium, comprising: determining if antibodies directed against at least 2 proteins comprising a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 6, are present in a biological sample of the individual, and deducing therefrom that the individual is infected by a staphylococcus bacterium.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: January 24, 2012
    Assignee: Ingen Biosciences
    Inventors: Camille Cyncynatus, Julie Roge, Damien Thomas, Helene Nuyttens
  • Use of the 7F4 protein in the in vitro diagnosis of infections
    Patent number: 8088592
    Abstract: A method for determining if an individual is infected by Mycoplasma pneumonia, including, determining if antibodies directed against a protein comprising SEQ ID NO: 2 are present in a biological sample of the individual, and deducing therefrom that the individual is infected by Mycoplasma pneumoniae.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: January 3, 2012
    Assignees: Ingen Biosciences, Universite Victor Segalen Bordeaux 2
    Inventors: Camille Cyncynatus, Helene Nuyttens
  • METHOD FOR DIAGNOSING STAPHYLOCOCCAL INFECTIONS
    Publication number: 20100227810
    Abstract: The present invention relates to a method for determining if an individual is infected by a staphylococcus bacterium, comprising: determining if antibodies directed against at least 2 proteins comprising a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 6, are present in a biological sample of the individual, and deducing therefrom that the individual is infected by a staphylococcus bacterium.
    Type: Application
    Filed: March 3, 2009
    Publication date: September 9, 2010
    Inventors: Camille Cyncynatus, Julie Roge, Damien Thomas, Helene Nuyttens
  • USE OF THE 7F4 PROTEIN IN THE IN VITRO DIAGNOSIS OF MYCOPLASMA PNEUMONIAE INFECTIONS
    Publication number: 20100136040
    Abstract: A method for determining if an individual is infected by Mycoplasma pneumonia, including, determining if antibodies directed against a protein comprising SEQ ID NO: 2 are present in a biological sample of the individual, and deducing therefrom that the individual is infected by Mycoplasma pneumoniae.
    Type: Application
    Filed: October 3, 2007
    Publication date: June 3, 2010
    Applicants: INGEN BIOSCIENCES, UNIVERSITE VICTOR SEGALEN BORDEAUX 2
    Inventors: Camille Cyncynatus, Helene Nuyttens
  • Cd4+ Survivin Epitopes and Uses Thereof
    Publication number: 20090004214
    Abstract: The invention concerns CD4+ T survivin epitopes and their vaccine and diagnostic uses.
    Type: Application
    Filed: September 28, 2006
    Publication date: January 1, 2009
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: XiaoFei Wang, Gaetan Munier, Sandra Moratille, Helene Nuyttens, Bernard Maillere